Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age.
Issuance: Department Circular No. 2022-0470
September 12, 2022Department Circular No. 2022-0470: Interim Operational Guidelines on the Implementation of Vaccination Activities during the BAKUNAHANG BAYAN: PINASLAKAS Special COVID-19 Vaccination Days (SVD) on September 26-30, 2022
Issuance: Department Memorandum No. 2022-0405
September 9, 2022Department Memorandum No. 2022-0405: Moratorium on Activities to Prioritize the Implementation of Bakunahang Bayan: PinasLakas Special COVID-19 Vaccination Days on September 26-30, 2022
Issuance: Department Memorandum No. 2022-0411
September 6, 2022Department Memorandum No. 2022-0411 “Guidelines Relative to Ramping up of COVID-19 Contact Tracing and Testing”
Issuance: Department Memorandum No. 2022-0397
September 1, 2022Department Memorandum No. 2022-0397 “Reiteration on the COVID-19 Testing of Public and Private Healthcare Workers”
Issuance: Department Memorandum No. 2022-0402
August 9, 2022Department Memorandum No. 2022-0402: Guidelines on the Management and Administration of Moderna (Spikevax) COVID-19 mRNA Vaccine to Pediatric Population Ages 6 to 11 Years Old
Issuance: Department Memorandum No. 2022-0206-A
July 26, 2022Department Memorandum No. 2022-0206-A Amendment to the DM No. 2022-0206: “Interim Operational Guidelines on the Administration of 2nd COVID-19 Vaccine Booster Doses to Senior Citizens and Frontline Healthcare Workers ages 18 years Old and Above”
Issuance: Department Circular No. 2022-0397
July 26, 2022Clarification and Updates on the Grant of COVID-19 Health Care Worker Benefits
Issuance: Department Memorandum No. 2022-0252
June 20, 2022Interim Operational Guidelines on the Administration of Additional Doses of Pfizer-BioNTech COVID-19 Vaccine to Immunocompromised Pediatric A3 ages 12 to 17 Years Old
Issuance: Department Memorandum No. 2022-0259
June 15, 2022Supplemental guidelines to the DOH-DBM JAO No. 2022-0001 for the processing of COVID-19 sickness and death compensation claims for eligible public and private health workers for calendar years 2020 and 2021
Issuance: Joint Circular No. 2022-0002
May 12, 2022Implementing Guidelines on the Grant of COVID-19 Sickness and Death Compensation to Eligible Public and Private Health Care Workers (HCWs) and Non-HCWs for FY 2022
Issuance: Department Memorandum No. 2022-0204
May 10, 2022Department Memorandum No. 2022-0204 “Guidelines on the Shifting from Pneumococcal Conjugate Vaccine 13 (PCV13) to Pneumococcal Conjugate Vaccine 10 (PCV10) in the Routine Immunization for Children”
Issuance: Department Memorandum No. 2022-0154
April 22, 2022Interim operational guidelines on the administration of 2nd COVID-19 vaccine booster doses to Immunocompromised Population (ICPs) ages 18 years old and above